Chargeback Validation

Chargebacks represent one of the most frequently sited areas of exposure for pharmaceutical revenue leakage. BioPharma and Generics companies are particularly exposed, with high levels of institutional sales and retail contracting. As PHS and 340b programs continue to grow and the contracted portion of the business expands, manufacturers in all industry segments are turning to DNA and its related services to identify missing reverse chargebacks, ineligible PHS-discounted shipments, and 340b program discrepancies.

IntegriChain Solutions for Chargeback Validation

Channel Sales

Integrate your 867 and 844/849 data to a single customer master. Ensure that pharmacies in all classes of trade are identified using the same ID number, so that your analysts can cross check chargebacks and reversals against 867 transaction level details and IntegriChain's gold standard class of trade.
read more >
Chargeback Validation

DNA's Chargeback Validation application streamlines the process of identifying and ranking 867-849 discrepancies. Use Chargeback Validation to identify specific member facilities where revenue leakage is occurring, and to locate the 867 and 844/849 line level details that relate to the discrepancy.
read more >
Chargeback Check-up

Have the Advanced Analytics team use Chargeback Validation to review up to two years of chargeback history for revenue leakage.
read more >